[size=0.875]ARTICLE | CLINICAL NEWS
PrEP-001: Ph IIa PrEP-CS-002 data[size=0.875]ALICIA PARKER
[size=0.875]17 ¦µ¦Å¦Â¦Ñ¦Ï¦Ô¦Á¦Ñί¦Ï¦Ô 2017 9:54 PM GMT+2
The double-blind Phase IIa PrEP-CS-002 trial in 39 evaluable patients with mild to moderate controlled asthma challenged with HRV-16 showed that PrEP-001 missed the primary endpoint of improving
|